# Remimazolam for Cataract Surgery

> **NCT05980117** · PHASE4 · RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 120 (estimated)

## Conditions studied

- Cataract Surgery
- Cognitive Impairment

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT05980117
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2025-12
- **Final completion:** 2026-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05980117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05980117, "Remimazolam for Cataract Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05980117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*